Plant Summary


  Plant Information

TCMBank_ID:

TCMBANKHE007579

ID:

TCMBANKHE007579

植物拉丁名:

Sargassum
显示图片

功能与主治:

To soften indurated mass, to eliminate phlegm and dissipate modulation, and to induce diuresis./1. Prevent and treat hypothyroidism caused by deficiency of iodine.2. Its aqueous infusion can lower blood pressure and inhibit the growth of trichophyton.3. Causing atrophy of mammary gland and decreasing milk secretion.

药用植物名:

海藻

药味:

Cold; Salty

经络:

Stomach; Kidney

临床特征:

1. Prevent and treat hypothyroidism caused by deficiency of iodine.2. Its aqueous infusion can lower blood pressure and inhibit the growth of trichophyton.3. Causing atrophy of mammary gland and decreasing milk secretion.

治疗类型:

化痰药

TCM_ID_id:

3646

SymMap_id:

159

TCMSP_id:

314


   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN005181 maesagenin a CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CC(C2(C(C1O)O)C=O)O)C)C)(C)C)O)C)C
TCMBANKIN009134 Diglycol dibenzoate EINECS 204-407-6; 2-(2-phenylcarbonyloxyethoxy)ethyl benzoate; Polyethylene glycol 100 dibenzoate; 2,2'-oxydiethylene dibenzoate; Ethanol, 2,2'-oxybis-, dibenzoate; Di(ethylene glycol) dibenzoate; 369365_ALDRICH; Polyoxyethylene (2) dibenzoate; BRN 2509507; AI3-02293; Oxydiethylene dibenzoate; Benzoic acid, diester with diethylene glycol; 4-09-00-00356 (Beilstein Handbook Reference); HSDB 5587; benzoic acid 2-[2-(oxo-phenylmethoxy)ethoxy]ethyl ester; DIETHYLENE GLYCOL, DIBENZOATE; Diethylene glycol dibenzoate; 120-55-8; Benzoyloxyethoxyethyl benzoate; benzoic acid 2-[2-(benzoyloxy)ethoxy]ethyl ester; 2-[2-(benzoyloxy)ethoxy]ethyl benzoate; NCGC00164149-01; Dibenzoyldiethyleneglycol ester; Benzo Flex 2-45 C18H18O5 314.33 C1=CC=C(C=C1)C(=O)OCCOCCOC(=O)C2=CC=CC=C2
TCMBANKIN010116 isothankunicacid C30H48O6 504.7 g/mol CC1CCC2(CCC3(C(=CCC4C3(CC(C5(C4(CCC(C5(C)CO)O)C)O)O)C)C2C1C)C)C(=O)O
TCMBANKIN011543 brahmic acid Madecassic acid; AC1L5ZR7; 8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid; SCHEMBL14286199; NSC88135; CHEMBL1993179; Brahmic acid; NCI60_041951; 8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; brahmicacid; AC1Q5V62; AKOS032948362; 4CN-1172; 18449-41-7; 2,3,6,23-tetrahydroxyurs-12-en-28-oic acid; NSC-88135; madecassic acid C30H48O6 504.7 CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)O
TCMBANKIN014118 OBT SR-01000640954-1; 2(3H)-Benzothiazolone; BENZTHIAZOLINE,2-ONE; MLS000737673; 2-Hydroxybenzothiazole; 2-Benzothiazolone; ZINC00395576; SBB005792; S-Orthophenylenethiocarbamate; NSC 33823; SMR000112468; 60362-05-2; AIDS019693; Carbamothioic acid, (2-mercatophenyl)-, .gamma.-lactone; 407607_ALDRICH; 2-Benzothiazolinone; c1130; ST5073356; 2-Benzothiazolinone (8CI); EINECS 213-281-1; NSC 7706; NSC26422; AI3-24484; Benzothiazolone; 3H-1,3-benzothiazol-2-one; 4464-59-9; ZINC00066150; MLS000697050; 934-34-9; 2-Benzothiazolol; NSC7706; 92353-21-4; NSC33823; NSC 26422; 1,3-Benzothiazol-2-ol; 1,3-benzothiazol-2(3H)-one; AIDS-019693; InChI=1/C7H5NOS/c9-7-8-5-3-1-2-4-6(5)10-7/h1-4H,(H,8,9; Carbamothioic acid, (2-mercatophenyl)-, gamma-lactone C7H5NOS 151.19 C1=CC=C2C(=C1)NC(=O)S2
TCMBANKIN014626 alginic acid BG01094448; AC-11039; L932; XJKJWTWGDGIQRH-IOPJEYNBSA-N; MFCD00081309; MolPort-039-144-939; (2R,4R,5S,6S)-3-{[(2R,3S,4R,5S,6S)-6-CARBOXY-3,4-DIHYDROXY-5-METHOXYOXAN-2-YL]OXY}-4,5-DIHYDROXY-6-METHYLOXANE-2-CARBOXYLIC ACID; C14H22O12; AKOS015960402 C14H22O12 382.32 g/mol CC1C(C(C(C(O1)C(=O)O)OC2C(C(C(C(O2)C(=O)O)OC)O)O)O)O
TCMBANKIN017982 cephalin 271.19 CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCCC
TCMBANKIN018009 Benzpinacol Benzophenone pinacol; NSC120377; 1,1,2,2-Tetraphenylethylene glycol; 464-72-2; 1,2-Ethanediol, 1,1,2,2-tetraphenyl-; alpha,alpha'-Bibenzhydrol; 1,1,2,2-Tetraphenyl-1,2-ethanediol; NSC 120377; AI3-09213; ZINC01251729; Benzpinacone; ST5308179; NSC1973; Tetraphenyl-1,2-ethanediol; EINECS 207-356-8; .alpha.,.alpha.'-Bibenzhydrol; B9807_ALDRICH; 1,1,2,2-tetra(phenyl)ethane-1,2-diol; Oprea1_328770; Benzopinacol; Benzopinacone; 88002_FLUKA; 1,1,2,2-Tetraphenylethane-1,2-diol; Tetraphenylethylene glycol C26H22O2 366.45 C1=CC=C(C=C1)C(C2=CC=CC=C2)(C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O
TCMBANKIN022495 4-methylsulfinyl butyl isothiocyanate Broccoli sprout extracts; 4-isothiocyanatobutyl methyl sulfoxide; Ambap4478-93-7; 7J94TPZ10L; CHEMBL48802; MFCD09039283; Y0196; SFN; MFCD00198068; Sulforaphan; Butane,1-isothiocyanato-4-[(R)-methylsulfinyl]-; 1-Isothiocyanato-4-(methylsulfinyl)butane #; 478S937; CTK4I8459; NSC749790; Sulforaphane (unspecified); I09-1948; CHEBI:47807; D,L-Sulforaphane; (-)1-Isothiocyanato-4R-methylsulfinyl)butane; DL-Sulforaphane, >=90% (HPLC), synthetic, liquid; Sulforathane; SUVMJBTUFCVSAD-UHFFFAOYSA-N; Butane,1-isothiocyanato-4-(methylsulfinyl)-; FCH834823; AK548473; GTPL6569; Sulforaphane Extract; VC31091; HY-13755; FT-0674750; CS-7809; 1-isothiocyanato-4-methylsulfinylbutane; 4-methylsulphinylbutyl glucosinolate; TRA0004535; 1-Isothiocyanato-4-(methylsulfinyl)-butane; Q-100160; AC1Q7EXG; 4-(Methylsulfinyl)Butyl Isothiocyanate; AC1L1K5N; BRD-A58955223-001-02-0; EBD8820; 1-Isothiocyanato-4-methylsulfinyl)butane; AKOS006282481; BDBM50073654; Sulforaphane Racemate; 4-Methylsulfinyl butyl isothiocyanate; DTXSID8036732; Butane, 1-isothiocyanato-4-(methylsulfinyl)-; R,S-Sulforaphane; UNII-7J94TPZ10L; LS-45925; 1-Isothiocyanato-4-(methylsulfinyl)butane; sulforaphane; 4478-93-7; BN0741; Butane, 1-isothiocyanato-4-(methylsulfinyl)-, (S)-; Sulforafan; Sulphoraphane; Butane, 1-isothiocyanato-4-((S)-methylsulfinyl)-; API0015875; C6H11NOS2; CCRIS 7221; Sulforaphane, (S)-; SCHEMBL105202; MolPort-003-850-350; NSC-749790; 1-isothiocyanato-4-methanesulfinylbutane; methylsulfoxybutylisothiocyanate; AB1008924; DL-Sulforaphane C6H11NOS2 177.3 g/mol CS(=O)CCCCN=C=S
TCMBANKIN026788 madecassicacid C30H48O6 504.7 g/mol CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)O
TCMBANKIN027774 ZINC04026398 C15H26O 222.37
TCMBANKIN029786 2,3-dihydro-1H-quinolin-4-one Oprea1_697248; Oprea1_507697 C9H7NO 145.16 C1CNC2=CC=CC=C2C1=O
TCMBANKIN036818 Asiatic acid NSC 166063; asiaticacid; Urs-12en-28-oic acid, 2,3,23-trihydroxy-, (2alpha, 3beta, 4alpha)-; Urs-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3beta,4alpha)-; (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,12a-hexamethyl-9-methylol-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; 464-92-6; C08617; Asiatic acid; Ambotz464-92-6; (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid 488.7
TCMBANKIN036903 madecassoside AS-15335; 34540-22-2; 540M222; AC-6056; C-23590; ZINC238808796; BG01195995; C48H78O20; BG01794331; BC202516; AKOS008901372; Q-100419; ASIATICOSIDE A; O905; BNMGUJRJUUDLHW-CIZDPPTDSA-N; MolPort-005-933-039; Ambap34540-22-2; Redermic; MFCD00017380; Madecassoside C48H78O21 991 [C@]1([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@]([H])([C@@]([H])(C([H])([H])[H])[C@](C([H])([H])[H])([H])C([H])([H])C2([H])[H])[C@@]2(C(O[C@@]([H])(O[C@@]([H])(C([H] )([H])O[C@@]([H])(O[C@@]([H])(C([H])([H])O[H])[C@]3([H])OO[C@@]([H])(O[C@@]([H])(C([H])([H])[H])[C@]4([H])O[H])[C@@]([H])(O[H])[C@]4([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@]5([H])O[H])[C@@]([H])(O [H])[C@]5([H])O[H])=O)C([H])([H])C6([H])[H])[C@@]67C([H])([H])[H])[C@@]7(C([H])([H])[H])C([H])([H])[C@@]8([H])O[H])[C@]8([H])[C@@](C([H])([H])O[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN038952 centellasaponin b C42H68O16 829 g/mol CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O
TCMBANKIN039128 Isofucosterol C08812; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methylhex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; C08821; AIDS113090; 481-14-1; isofucosterol; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methyl-hex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; AIDS-113090; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 18472-36-1; delta5-Avenasterol C29H48O 412.69 CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C
TCMBANKIN039539 Centellasaponin D 959.1 g/mol
TCMBANKIN040287 madasiatic acid AC1NSXQ6; (1S,4aS,6bR,8R,10R,12aR,14bS)-8,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; madasiaticacid C30H48O5 488.7 CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)C)O)O)C)O)C)C2C1C)C)C(=O)O
TCMBANKIN042669 asiaticoside 2-[[10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picen-4a-yl]methoxy]-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methyl-2-oxanyl]oxymethyl]oxane-3,4,5-triol; 6-methyloxane-2,3,4,5-tetrol; A827054; 2-[[9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-10,11-bis(oxidanyl)-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picen-4a-yl]methoxy]-6-[[6-(hydroxymethyl)-5-methyl-3,4-bis(oxidanyl)oxan-2-yl]oxymethyl]oxane-3,4,5-triol; 6-methyloxane-2,3,4,5-te C48H78O20 975 [C@]1([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@]([H])([C@@]([H])(C([H])([H])[H])[C@](C([H])([H])[H])([H])C([H])([H])C2([H])[H])[C@@]2(C(O[C@@]([H])(O[C@@]([H])(C([H] )([H])O[C@@]([H])(O[C@@]([H])(C([H])([H])O[H])[C@]3([H])OO[C@@]([H])(O[C@@]([H])(C([H])([H])[H])[C@]4([H])O[H])[C@@]([H])(O[H])[C@]4([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@]5([H])O[H])[C@@]([H])(O [H])[C@]5([H])O[H])=O)C([H])([H])C6([H])[H])[C@@]67C([H])([H])[H])[C@@]7(C([H])([H])[H])C([H])([H])C8([H])[H])[C@]8([H])[C@@](C([H])([H])O[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN043586 Centellasaponin C 959.1 g/mol
TCMBANKIN043766 4-Hydroxy-3-indolyl methyl glucosinolate 463.5 g/mol
TCMBANKIN045605 sceffoleoside a CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C(C6(CC5)C)(CCC8C7(CC(C(C8(C)CO)O)O)C)C)(C)C)O)O)O)CO)O)O)O
TCMBANKIN049452 asiaticoside b CHEMBL449193; asiaticoside-b C48H78O20 975.1 g/mol CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CC(C(C(C8C(CC7(C6(CC5)C)C)O)(C)CO)O)O)C)(C)C)O)O)O)CO)O)O)O
TCMBANKIN058188 PHB NSC4961; AE-848/32195059; AIDS-018038; AI3-01003; 4-Hydroxybenzoic acid; Benzoic acid, p-hydroxy-; ST5210584; 54630_FLUKA; C00156; 4-HBA; InChI=1/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10; Acido p-idrossibenzoico [Italian]; HSDB 7233; 99-96-7; p-Salicylic acid; p-Oxybenzoesaure [German]; HYDROXYBENZOIC ACID, PARA; NSC 4961; Benzoic acid, p-hydroxy; EINECS 202-804-9; CHEBI:30763; p-Hydroxybenzoic acid; H20059_ALDRICH; 240141_ALDRICH; NCGC00166040-01; Kyselina 4-hydroxybenzoova [Czech]; 4-Carboxyphenol; Benzoic acid, 4-hydroxy; W398608_ALDRICH; 4-Hydroxybenzoesaeure; Benzoic acid, 4-hydroxy-; AIDS018038; WLN: QVR DQ; 4-hydroxybenzoic; 4-hydroxy benzoic acid C7H6O3 138.12 g/mol C1=CC(=CC=C1C(=O)O)O
TCMBANKIN058281 NK 90-02-8; 2-HYDROXY-BENZALDEHYDE; 03273_FLUKA; 27761-48-4; Salicylal; C06202; Salizylaldehyd; 4-08-00-00176 (Beilstein Handbook Reference); Salicyladehyde; Salicylic aldehyde; c0337; AIDS-017916; InChI=1/C7H6O2/c8-5-6-3-1-2-4-7(6)9/h1-5,9; HSDB 721; o-Formylphenol; CHEBI:16008; Benzaldehyde, 2-hydroxy-; Benzaldehyde, o-hydroxy-; ZINC00896073; W300403_ALDRICH; S356_ALDRICH; CCRIS 7451; WLN: VHR BQ; NSC 49178; ST5213374; AIDS017916; NSC187662; AI3-02174; 2-Hydroxybenzaldehyde; 84160_FLUKA; FEMA No. 3004; o-Hydroxybenzaldehyde; 2-Formylphenol; NSC49178; BRN 0471388; EINECS 201-961-0; Salicylaldehyd; Salicylaldehyde C7H6O2 122.12 g/mol C1=CC=C(C(=C1)C=O)O
TCMBANKIN058332 aurantiamide;N-[(1S)-1-(benzyl)-2-[[(1S)-1-(benzyl)-2-hydroxy-ethyl]amino]-2-keto-ethyl]benzamide 58115-31-4; N-[(2S)-1-[[(2S)-1-hydroxy-3-phenyl-propan-2-yl]amino]-1-oxo-3-phenyl-propan-2-yl]benzamide; N-[(2S)-1-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]benzamide; N-[(1S)-2-[[(1S)-1-(hydroxymethyl)-2-phenylethyl]amino]-2-oxo-1-(phenylmethyl)ethyl]benzamide; N-[(1S)-2-[[(1S)-1-(hydroxymethyl)-2-phenyl-ethyl]amino]-2-oxo-1-(phenylmethyl)ethyl]benzamide C25H26N2O3 402.5 g/mol C1=CC=C(C=C1)CC(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3=CC=CC=C3
TCMBANKIN058363 n-phenyl-2-naphthylamine Fenyl-beta -naftylamin; Phenyl-beta-naphtilamine; 4-12-00-03128 (Beilstein Handbook Reference); I14-13875; AC1L1RHP; NCGC00091111-05; W-108255; N-.beta.-Naphthyl-N-phenylamine; MLS002608023; KEQFTVQCIQJIQW-UHFFFAOYSA-N; N-Phenyl-beta -naphthylamine; Antioxidant PBN; N-2-Naphthylaniline; DTXSID4021131; AC-13068; 52907-17-2; CCRIS 853; N-Phenyl-2-naphthylamine; NCGC00091111-01; HSDB 2888; N-beta-Naphthyl-N-phenylamine; KB-55551; N-Phenyl-beta-naphthylamine; CJ-27101; Fenyl-beta-naftylamin; ACMC-209c4p; P.B.N; A807001; Fenyl-beta-naftylamin [Czech]; Stabilizer AR; RL01609; UNII-456KT854AJ; 2-naphthalenamine,n-phenyl-; KS-00000VGP; AC1Q1IST; AN-23110; Jsp002174; DSSTox_RID_75962; 2-naphthylaniline; Naftam 2; NSC 37151; N-Phenyl-2-naphthylamine, 97%; 135-88-6; 2-(N-Phenylamino)naphthalene; N-beta -naphthyl-N-phenylamine; Phenyl-2-naphthylamine; T6903; NCGC00259440-01; Phenyl-beta-naphthylamine; CHEBI:34877; V0380; N-Fenyl-2-aminonaftalen [Czech]; beta-Naphthylphenylamine; SCHEMBL6435930; Oprea1_737712; Neozone; 2-Naphthylphenylamine; 2-Anilinonaphthalene; N-Phenyl-.beta.-amino-naphthalene; STK367409; 2-Phenylaminonaphthalene; Stabilator AR; PBNA; AJ-29138; BIDD:ER0357; EINECS 205-223-9; SCHEMBL38433; NCGC00091111-02; Antioxidant 116; NCGC00256440-01; ac eto pbn; Neozone D; DB-063104; KSC491Q7L; NSC37151; Noclizer D; AKOS001426472; Nocrac D; Neosone D; 2-NAPHTHYLAMINE, N-PHENYL-; Aceto PBN; CTK3J1875; CJ-06100; 2-Naphthalenamine, N-phenyl-; AK-58488; AI3-00068; Fenyl-.beta.-naftylamin; MCULE-5821072787; NCGC00091111-03; InChI=1/C16H13N/c1-2-8-15(9-3-1)17-16-11-10-13-6-4-5-7-14(13)12-16/h1-12,17; Vulkanox PBN; 456KT854AJ; ST50165453; Nonox DN; phenyl-b-naphthylamine; 2-(n-phenylamino)-naphthalene; N-Phenyl-2-naphthalenamine; 84420-28-0; N-Phenyl-.beta.-naphthylamine; neosone d; [2]naphthyl-phenyl-amine; RTR-004823; DSSTox_CID_1131; CHEMBL1543632; beta -naphthylphenylamine; AC1Q4TNM; N-(2-Naphthyl)-N-phenylamine; NSC-37151; BBL000386; ZINC1669780; C14694; .beta.-Naphthylphenylamine; P0198; Neozon D; A-naphthylamine; Nonox DNStabilizer AR; NCGC00091111-04; Stabilator A.R; WLN: L66J CMR; N-Fenyl-2-aminonaftalen; CAS-135-88-6; LS-19; N-Phenylnaphthalen-2-amine; AgeRite Powder; Nilox PBNA; Tox21_201891; TRA0097315; TR-004823; ST24031437; Nonox D; DSSTox_GSID_21131; NCI-C02915; SMR000112180; phenyl-beta -naphthylamine; AK 1 (stabilizer); N-(2-Naphthyl)aniline; ANW-19991; MFCD00004052; Stabilizator AR; BRN 2211188; MolPort-000-514-795; Antioxygene MC; Tox21_302900; Anilinonaphthalene; N-phenyl-N-; Phenyl-.beta.-naphthylamine;135-88-6; Aceto PBN; WLN: L66J CMR; Phenyl-beta-naphtilamine; Phenyl-2-naphthylamine; 4-12-00-03128 (Beilstein Handbook Reference); Phenyl-beta-naphthylamine; AIDS417346; 2-Naphthalenamine, N-phenyl-; AI3-00068; N-Fenyl-2-aminonaftalen [Czech]; N-phenyl-2-naphthalenamine; InChI=1/C16H13N/c1-2-8-15(9-3-1)17-16-11-10-13-6-4-5-7-14(13)12-16/h1-12,17; Vulkanox PBN; AgeRite Powder; beta-Naphthylphenylamine; Nilox PBNA; Oprea1_737712; Neozone; 2-Anilinonaphthalene; 2-Naphthylphenylamine; N-Phenyl-.beta.-amino-naphthalene; Nonox DN; 2-Phenylaminonaphthalene; Antioxidant PBN; N-2-Naphthylaniline; 52907-17-2; CCRIS 853; 84420-28-0; N-Phenyl-2-naphthylamine; N-Phenyl-.beta.-naphthylamine; NCGC00091111-01; ZINC01669780; HSDB 2888; N-Phenyl-beta-naphthylamine; 178055_ALDRICH; EINECS 205-223-9; NCI-C02915; AIDS-417346; NCGC00091111-02; Fenyl-beta-naftylamin [Czech]; AK 1 (stabilizer); Stabilizer AR; Antioxidant 116; N-(2-Naphthyl)aniline; N-phenylnaphthalen-2-amine; Stabilizator AR; 2-Naphthylamine, N-phenyl-; Neozone D; NSC37151; C14694; AK 1; ST5165453; Noclizer D; 2-naphthyl-phenyl-amine; BRN 2211188; NSC 37151; Naftam 2; Nocrac D; .beta.-Naphthylphenylamine; Anilinonaphthalene; Neozon D; Phenyl-.beta.-naphthylamine;Nonox D C16H13N 219.28 g/mol C1=CC=C(C=C1)NC2=CC3=CC=CC=C3C=C2
TCMBANKIN058436 2, 4-dihydroxy pyrimidine NSC3970; C00106; 16908-84-2; U3879_SIGMA; 2,4-Pyrimidinediol; 2-hydroxy-4(3H)-pyrimidinone; 66-22-8; Pirod; 144104-68-7; SQ 7726; Uracil-2-14C; 2,4-Pyrimidinedione; 4433-21-0; D00027; 24897-50-5; U0750_SIGMA; AI3-25470; 766-19-8; U1128_SIGMA; SQ 8493; ST5165192; SQ 6201; 2-hydroxy-4(1H)-pyrimidinone; 2,4-Dioxopyrimidine; 1H-pyrimidine-2,4-dione; Urazil; Pyrod; EINECS 200-621-9; Hybar X; Uracil (JAN/USAN); CHEBI:17568; 6-(3,5-Dimethylbenzyl)-5-ethyl-1-[4-(13-ethyl-17-hydroxy-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylethynyl)benzyloxymethyl]uracil; Uracil-5-d; NCIMech_000782; AC-907/30002021; 2,4-Dihydroxypyrimidine; 42910-77-0; NSC 3970; NSC29742; ZINC00895045; STK301734; AIDS009895; Uracil (8CI); URACIL; Uracil [USAN]; 6-[(3,5-dimethylphenyl)methyl]-5-ethyl-1-[[4-[2-(13-ethyl-17-hydroxy-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)ethynyl]phenyl]methoxymethyl]pyrimidine-2,4-dione; pyrimidine-2,4(1H,3H)-dione; 4433-24-3; 2,4-(1H,3H)-pyrimidinedione (9CI); CCRIS 3077; RU 12709; Ura; 2,4(1H,3H)-Pyrimidinedione; BMS 205603-01; InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8; 2,4(1H,3H)-Pyrimidinedione (9CI); NCI60_003718; 4-hydroxy-2(1H)-pyrimidinone; 2,4(1H,3H)-Pyrimidinedione, labeled with tritium; AIDS-009895 C4H4N2O2 112.09 g/mol C1=CNC(=O)NC1=O
TCMBANKIN059272 diisobutyl phthalate di-isobutyl phthalate;ST5405544; diisobutyl benzene-1,2-dicarboxylate; benzene-1,2-dicarboxylic acid diisobutyl ester; Di-iso-butyl phthalate; 80130_FLUKA; Isobutyl phthalate; bis(2-methylpropyl) benzene-1,2-dicarboxylate; (C4-C13) Branched alkyl alcohols, phthalic anhydride ester; ZINC00388318; EINECS 201-553-2; NSC15316; 1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester; Diisobutyl phthalate; 152641_ALDRICH; EINECS 273-157-8; 68951-39-3; C15205; AI3-04278; Phthalic acid, diisobutyl ester; BRN 2054802; NCGC00091360-01; NSC 15316; WLN: 1Y1&1OVR BVO1Y1&1; 4-09-00-03177 (Beilstein Handbook Reference); Diisobutylester kyseliny ftalove [Czech]; Hexaplas M/1B; 1,2-Benzenedicarboxylic acid, C4-13-branched alkyl esters; AI3-04278 (USDA); Kodaflex DIBP; 68955-80-6; Hatcol DIBP; HSDB 5247; CCRIS 6193; di-l-butyl phthalate (DIBP); Di(i-butyl)phthalate; SMR000112470; MLS000516002; 84-69-5; Palatinol IC C16H22O4- C6H4[CO2CH2CH(CH3)2]2 278.34 g/mol CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C
TCMBANKIN059531 eucalyptol C10H18O 154.25 g/mol CC1(C2CCC(O1)(CC2)C)C
TCMBANKIN060039 THM C10H14N2O5 242.23 g/mol CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O
TCMBANKIN060044 5-methyluracil C5H6N2O2 126.11 g/mol CC1=CNC(=O)NC1=O
TCMBANKIN060370 pinocamphone C10H16O 152.23 g/mol CC1C2CC(C2(C)C)CC1=O
TCMBANKIN060524 madecassicacid C30H48O6 504.7 g/mol CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)O
TCMBANKIN060536 asiatic acid C30H48O5 488.7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)O
TCMBANKIN061207 Di-n-butyl phthalate C16H22O4 278.34 g/mol CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC

   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献

   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型